Cryoport, Inc.
- Last sale
- Nov 6, 2026 · +19.23%
- Market cap
- $968.38M
- 50.7M shares
- Filings
- 1,014
Q3 2026+12.4% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+633.8% FY25 yoy
- $968.38M
- —
- 5.0×
- 2.0×
- -1.94%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 6, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $176,177,000 | reported | |
| FY 2024 | 2024-12-31 | $156,769,000 revised | reported | |
| FY 2023 | 2023-12-31 | $168,662,000 revised | reported | |
| FY 2022 | 2022-12-31 | $237,277,000 | reported | |
| FY 2020 | 2021-12-31 | $222,608,000 | reported | |
| FY 2019 | 2020-12-31 | $78,696,000 | reported | |
| FY 2018 | 2019-12-31 | $33,942,000 | reported | |
| FY 2017 | 2017-12-31 | $11,954,267 | reported | |
| FY 2016 | 2016-12-31 | $7,678,816 | reported | |
| FY 2015 | 2015-03-31 | $3,935,320 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $10.01M | $10.01M | — | 49.86M sh | −0.1% | — |
| FY2022 | — | $37.96M | $37.96M | — | 48.34M sh | — | — |
| FY2021 | — | $0.00 | $0.00 | — | — | — | — |
| FY2020 | — | $0.00 | $0.00 | — | 49.69M sh | +24.7% | — |
Segments
LineFY2025ShareChange
Life Sciences Services$101.03M57%+18.4%
Life Sciences Products$75.15M43%+5.2%
Life Science Supply Chain Solutions———
Life Science Systems———
Total$176.18M
Pharmaceutical preparations
Cryoport, Inc. is the 90th largest of the 552 covered companies the SEC files under this code, by revenue. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
RYTMRhythm Pharmaceuticals, Inc.$189.8M45.8%103.6%$7.6BMRVIMaravai Lifesciences Holdings, Inc.$185.7M28.3%70.4%$2.0BSTOKStoke Therapeutics, Inc.$184.4M404.5%3.7%$1.7BLFVNLifevantage Corp$182.6M20.1%2.8%$64.0MKMDAKamada Ltd$180.5M12.1%11.2%$452.8M
CYRXCryoport, Inc. (this company)$176.2M12.4%44.4%$968.4M
PHATPhathom Pharmaceuticals, Inc.$175.1M216.9%126.3%$506.9MSNDXSyndax Pharmaceuticals Inc$172.4M627.8%165.6%$1.3BLQDALiquidia Corp$158.3M1,031.2%43.5%$5.2BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cryoport, Inc. · CIK 1124524 · Engraved from SEC EDGAR